Arbutus Biopharma Corp
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Arbutus Biopharma Corp through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Arbutus Biopharma Corp through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Vor Biopharma (NYSE:VOR) Price Target Cut to $16.00 by Analysts at Truist Financial via ETF Daily News
Arbutus Biopharma Corp Performance
Active Alerts for IEX:ABUS
You don't have any alerts set for IEX:ABUS.
About Arbutus Biopharma Corp
Arbutus Biopharma Corporation is a biopharmaceutical company primarily dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses (including COVID-19).
Real-time ABUS to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.